tiprankstipranks
Trending News
More News >

Saniona Converts Remaining Convertibles with Fenja Capital

Story Highlights
Saniona Converts Remaining Convertibles with Fenja Capital

Don’t Miss TipRanks’ Half-Year Sale

Saniona AB ( (SE:SANION) ) just unveiled an announcement.

Saniona AB announced that Fenja Capital II A/S has requested the conversion of its remaining outstanding convertibles, totaling SEK 6 million, into shares. This conversion will result in the issuance of 1,941,747 new shares, increasing the total number of shares by approximately 1.41% and slightly diluting existing shares and votes. The move reflects Saniona’s ongoing financial maneuvers to manage its capital structure effectively.

More about Saniona AB

Saniona is a clinical-stage biopharmaceutical company focused on neurological and psychiatric diseases. It has a diverse internal pipeline targeting conditions like epilepsy and major depressive disorder, and engages in strategic collaborations with companies such as Acadia Pharmaceuticals and Productos Medix. Saniona is based in Copenhagen and listed on Nasdaq Stockholm Main Market.

Average Trading Volume: 693,017

Current Market Cap: SEK1.36B

For detailed information about SANION stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1